Ergothioneine and its congeners: anti-ageing mechanisms and pharmacophore biosynthesis

Abstract

Ergothioneine, Ovothiol, and Selenoneine are sulfur/selenium-containing histidine-derived natural products widely distributed across different organisms. They exhibit significant antioxidant properties, making them as potential lead compounds for promoting health. Increasing evidence suggests that Ergothioneine is positively correlated with healthy ageing and longevity. The mechanisms underlying Ergothioneine’s regulation of the ageing process at cellular and molecular levels are beginning to be understood. In this review, we provide an in-depth and extensive coverage of the anti-ageing studies on Ergothioneine and discuss its possible intracellular targeting pathways. In addition, we highlight the recent efforts in elucidating the biosynthetic details for Ergothioneine, Ovothiol, and Selenoneine, with a particular focus on the study of their pharmacophore-forming enzymology.

Keywords

Ergothioneine / antioxidant / anti-ageing / longevity / biosynthesis / enzymology

References

[1] Akanmu D, Cecchini R, Aruoma OI et al. The antioxidant action of ergothioneine. Arch Biochem Biophys 1991;288:10–16.

[2] Ames BN. Prolonging healthy aging: longevity vitamins and proteins. Proc Natl Acad Sci USA 2018;115:10836–10844.

[3] Ando C, Morimitsu Y. A proposed antioxidation mechanism of ergothioneine based on the chemically derived oxidation product hercynine and further decomposition products. Biosci Biotechnol Biochem 2021;85:1175–1182.

[4] Apparoo Y, Phan CW, Kuppusamy UR et al. Ergothioneine and its prospects as an anti-ageing compound. Exp Gerontol 2022;170:111982.

[5] Arora I, Sharma M, Tollefsbol TO. Combinatorial epigenetics impact of polyphenols and phytochemicals in cancer prevention and therapy. Int J Mol Sci 2019;20:4567.

[6] Aruoma OI, Whiteman M, England TG et al. Antioxidant action of ergothioneine: assessment of its ability to scavenge peroxynitrite. Biochem Biophys Res Commun 1997;231:389–391.

[7] Asahi T, Wu X, Shimoda H et al. A mushroom-derived amino acid, ergothioneine, is a potential inhibitor of inflammation-related DNA halogenation. Biosci Biotechnol Biochem 2016;80:313–317.

[8] Ba DM, Gao X, Al-Shaar L et al. Mushroom intake and cognitive performance among US older adults: the National Health and Nutrition Examination Survey, 2011–2014. Br J Nutr 2022;128:2241–2248.

[9] Balaban RS, Nemoto S, Finkel T. Mitochondria, oxidants, and aging. Cell 2005;120:483–495.

[10] Bazela K, Solyga-Zurek A, Debowska R et al. l-Ergothioneine protects skin cells against UV-induced damage—a preliminary study. Cosmetics 2014;1:51–60.

[11] Beetch M, Harandi-Zadeh S, Shen K et al. Dietary antioxidants remodel DNA methylation patterns in chronic disease. Br J Pharmacol 2020;177:1382–1408.

[12] Beliaeva MA, Seebeck FP. Discovery and characterization of the metallopterin-dependent ergothioneine synthase from Caldithrix abyssi. JACS Au 2022;2:2098–2107.

[13] Borodina I, Kenny LC, Mccarthy CM et al. The biology of ergothioneine, an antioxidant nutraceutical. Nutr Res Rev 2020;33:190–217.

[14] Brancaccio M, Milito A, Viegas CA et al. First evidence of dermo-protective activity of marine sulfur-containing histidine compounds. Free Radic Biol Med 2022;192:224–234.

[15] Braunshausen A, Seebeck FP. Identification and characterization of the first ovothiol biosynthetic enzyme. J Am Chem Soc 2011;133:1757–1759.

[16] Brunet A, Sweeney LB, Sturgill JF et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 2004;303:2011–2015.

[17] Burn R, Misson L, Meury M et al. Anaerobic origin of ergothioneine. Angew Chem Int Ed Engl 2017;56:12508–12511.

[18] Camarena V, Huff TC, Wang G. Epigenomic regulation by labile iron. Free Radic Biol Med 2021;170:44–49.

[19] Carlsson J, Kierstan MP, Brocklehurst K. Reactions of L-ergothioneine and some other aminothiones with2,2′-and 4,4′-dipyridyl disulphides and of L-ergothioneine with iodoacetamide. 2-Mercaptoimidazoles, 2- and 4-thiopyridones, thiourea and thioacetamide as highly reactive neutral sulphur nucleophils. Biochem J 1974;139:221–235.

[20] Castellano I, Seebeck FP. On ovothiol biosynthesis and biological roles: from life in the ocean to therapeutic potential. Nat Prod Rep 2018;35:1241–1250.

[21] Cheah IK, Halliwell B. Could ergothioneine aid in the treatment of coronavirus patients? Antioxidants 2020;9:595.

[22] Cheah IK, Ong RL, Gruber J et al. Knockout of a putative ergothioneine transporter in Caenorhabditis elegans decreases lifespan and increases susceptibility to oxidative damage. Free Radic Res 2013;47:1036–1045.

[23] Cheah IK, Feng L, Tang RMY et al. Ergothioneine levels in an elderly population decrease with age and incidence of cognitive decline; a risk factor for neurodegeneration? Biochem Biophys Res Commun 2016;478:162–167.

[24] Cheah IK, Tang RM, Yew TS et al. Administration of pure ergothioneine to healthy human subjects: uptake, metabolism, and effects on biomarkers of oxidative damage and inflammation. Antioxid Redox Signal 2017;26:193–206.

[25] Chen D, Steele AD, Lindquist S et al. Increase in activity during calorie restriction requires Sirt1. Science 2005;310:1641.

[26] Chen L, Naowarojna N, Song H et al. Use of a tyrosine analogue to modulate the two activities of a nonheme iron enzyme OvoA in ovothiol biosynthesis, cysteine oxidation versus oxidative C–S bond formation. J Am Chem Soc 2018;140:4604–4612.

[27] Chen L, Naowarojna N, Chen B et al. Mechanistic studies of a nonheme iron enzyme OvoA in ovothiol biosynthesis using a tyrosine analogue, 2-Amino-3-(4-hydroxy-3-(methoxyl) phenyl) Propanoic Acid (MeOTyr). ACS Catal 2019;9:253–258.

[28] Cheng R, Wu L, Lai R et al. Single-step replacement of an unreactive C–H bond by a C–S bond using polysulfide as the direct sulfur source in anaerobic ergothioneine biosynthesis. ACS Catal 2020;10:8981–8994.

[29] Cheng R, Lai R, Peng C et al. Implications for an imidazol-2-yl carbene intermediate in the rhodanase-catalyzed C–S bond formation reaction of anaerobic ergothioneine biosynthesis. ACS Catal 2021;11:3319–3334.

[30] Cheng R, Weitz AC, Paris J et al. OvoA(Mtht) from Methyloversatilis thermotolerans ovothiol biosynthesis is a bifunction enzyme: thiol oxygenase and sulfoxide synthase activities. Chem Sci 2022;13:3589–3598.

[31] Colognato R, Laurenza I, Fontana I et al. Modulation of hydrogen peroxide-induced DNA damage, MAPKs activation and cell death in PC12 by ergothioneine. Clin Nutr 2006;25:135–145.

[32] D’onofrio N, Servillo L, Giovane A et al. Ergothioneine oxidation in the protection against high-glucose induced endothelial senescence: involvement of SIRT1 and SIRT6. Free Radic Biol Med 2016;96:211–222.

[33] D’onofrio N, Martino E, Balestrieri A et al. Diet-derived ergothioneine induces necroptosis in colorectal cancer cells by activating the SIRT3/MLKL pathway. FEBS Lett 2022;596:1313–1329.

[34] Dare A, Channa ML, Nadar A. L-Ergothioneine and its combination with metformin attenuates renal dysfunction in type-2 diabetic rat model by activating Nrf2 antioxidant pathway. Biomed Pharmacother 2021;141:111921.

[35] Dare A, Elrashedy AA, Channa ML et al. Cardioprotective effects and in-silico antioxidant mechanism of L-ergothioneine in experimental type-2 diabetic rats. Cardiovasc Hematol Agents Med Chem 2022;20:133–147.

[36] De Luna P, Bushnell EA, Gauld JW. A density functional theory investigation into the binding of the antioxidants ergothioneine and ovothiol to copper. J Phys Chem A 2013;117:4057–4065.

[37] Dinkova-Kostova AT, Holtzclaw WD, Cole RN et al. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci USA 2002;99:11908–11913.

[38] Dumitrescu DG, Gordon EM, Kovalyova Y et al. A microbial transporter of the dietary antioxidant ergothioneine. Cell 2022;185:4526–4540.e18.

[39] Faponle AS, Seebeck FP, De Visser SP. Sulfoxide synthase versus cysteine dioxygenase reactivity in a nonheme iron enzyme. J Am Chem Soc 2017;139:9259–9270.

[40] Finkel T, Deng CX, Mostoslavsky R. Recent progress in the biology and physiology of sirtuins. Nature 2009;460:587–591.

[41] Forman HJ, Zhang H. Targeting oxidative stress in disease: promise and limitations of antioxidant therapy. Nat Rev Drug Discov 2021;20:689–709.

[42] Fu TT, Shen L. Ergothioneine as a natural antioxidant against oxidative stress-related diseases. Front Pharmacol 2022;13:850813.

[43] Ganesh Yerra V, Negi G, Sharma SS et al. Potential therapeutic effects of the simultaneous targeting of the Nrf2 and NF-kappaB pathways in diabetic neuropathy. Redox Biol 2013;1:394–397.

[44] Garcia-Gimenez JL, Pallardo FV. Maintenance of glutathione levels and its importance in epigenetic regulation. Front Pharmacol 2014;5:88.

[45] Garcia-Gimenez JL, Ibanez-Cabellos JS, Seco-Cervera M et al. Glutathione and cellular redox control in epigenetic regulation. Free Radic Biol Med 2014;75:S3.

[46] Goncharenko KV, Seebeck FP. Conversion of a non-heme iron-dependent sulfoxide synthase into a thiol dioxygenase by a single point mutation. Chem Commun (Camb) 2016;52:1945–1948.

[47] Goncharenko KV, Vit A, Blankenfeldt W et al. Structure of the sulfoxide synthase EgtB from the ergothioneine biosynthetic pathway. Angew Chem Int Ed Engl 2015;54:2821–2824.

[48] Goncharenko KV, Flückiger S, Liao C et al. Selenocysteine as a substrate, an inhibitor and a mechanistic probe for bacterial and fungal iron-dependent sulfoxide synthases. Chemistry 2020;26:1328–1334.

[49] Gründemann D, Harlfinger S, Golz S et al. Discovery of the ergothioneine transporter. Proc Natl Acad Sci USA 2005;102:5256–5261.

[50] Gründemann D, Hartmann L, Flogel S. The ergothioneine transporter (ETT): substrates and locations, an inventory. FEBS Lett 2022;596:1252–1269.

[51] Guillaumet-Adkins A, Yanez Y, Peris-Diaz MD et al. Epigenetics and oxidative stress in aging. Oxid Med Cell Longev 2017;2017:9175806.

[52] Halliwell B. Reflections of an aging free radical. Free Radic Biol Med 2020;161:234–245.

[53] Halliwell B, Cheah IK, Tang RMY. Ergothioneine—a diet-derived antioxidant with therapeutic potential. FEBS Lett 2018;592:3357–3366.

[54] Halliwell B, Tang RMY, Cheah IK. Diet-derived antioxidants: the special case of ergothioneine. Annu Rev Food Sci Technol 2023;14:323–345.

[55] Hartmann L, Seebeck FP, Schmalz HG et al. Isotope-labeled ergothioneine clarifies the mechanism of reaction with singlet oxygen. Free Radic Biol Med 2023;198:12–26.

[56] Hasty P, Campisi J, Hoeijmakers J et al. Aging and genome maintenance: lessons from the mouse? Science 2003;299:1355–1359.

[57] Hayes JD, Dinkova-Kostova AT. The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends Biochem Sci 2014;39:199–218.

[58] Hiebert P, Wietecha MS, Cangkrama M et al. Nrf2-mediated fibroblast reprogramming drives cellular senescence by targeting the matrisome. Dev Cell 2018;46:145–161.e10.

[59] Hitchler MJ, Domann FE. An epigenetic perspective on the free radical theory of development. Free Radic Biol Med 2007;43:1023–1036.

[60] Hitchler MJ, Domann FE. The epigenetic and morphogenetic effects of molecular oxygen and its derived reactive species in development. Free Radic Biol Med 2021;170:70–84.

[61] Hoeijmakers JH. DNA damage, aging, and cancer. N Engl J Med 2009;361:1475–1485.

[62] Hondal RJ. Selenium vitaminology: the connection between selenium, vitamin C, vitamin E, and ergothioneine. Curr Opin Chem Biol 2023;75:102328.

[63] Hong F, Freeman ML, Liebler DC. Identification of sensor cysteines in human Keap1 modified by the cancer chemopreventive agent sulforaphane. Chem Res Toxicol 2005;18:1917–1926.

[64] Horvath S. DNA methylation age of human tissues and cell types. Genome Biol 2013;14:R115.

[65] Horvath S, Raj K. DNA methylation-based biomarkers and the epigenetic clock theory of ageing. Nat Rev Genet 2018;19:371–384.

[66] Hseu YC, Lo HW, Korivi M et al. Dermato-protective properties of ergothioneine through induction of Nrf2/ARE-mediated antioxidant genes in UVA-irradiated human keratinocytes. Free Radic Biol Med 2015;86:102–117.

[67] Hseu YC, Vudhya Gowrisankar Y, Chen XZ et al. The antiaging activity of ergothioneine in UVA-irradiated human dermal fibroblasts via the inhibition of the AP-1 pathway and the activation of Nrf2-mediated antioxidant genes. Oxid Med Cell Longev 2020;2020:2576823.

[68] Hu W, Song H, Sae Her A et al. Bioinformatic and biochemical characterizations of C–S bond formation and cleavage enzymes in the fungus Neurospora crassa ergothioneine biosynthetic pathway. Org Lett 2014;16:5382–5385.

[69] Huang K, Huang J, Xie X et al. Sirt1 resists advanced glycation end products-induced expressions of fibronectin and TGF-beta1 by activating the Nrf2/ARE pathway in glomerular mesangial cells. Free Radic Biol Med 2013;65:528–540.

[70] Imai S, Guarente L. NAD+ and sirtuins in aging and disease. Trends Cell Biol 2014;24:464–471.

[71] Jacob C. A scent of therapy: pharmacological implications of natural products containing redox-active sulfur atoms. Nat Prod Rep 2006;23:851–863.

[72] Jang JH, Aruoma OI, Jen LS et al. Ergothioneine rescues PC12 cells from beta-amyloid-induced apoptotic death. Free Radic Biol Med 2004;36:288–299.

[73] Jia G, Fu Y, Zhao X et al. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol 2011;7:885–887.

[74] Jing H, Lin H. Sirtuins in epigenetic regulation. Chem Rev 2015;115:2350–2375.

[75] Kakhlon O, Cabantchik ZI. The labile iron pool: characterization, measurement, and participation in cellular processes(1). Free Radic Biol Med 2002;33:1037–1046.

[76] Kalous KS, Wynia-Smith SL, Smith BC. Sirtuin oxidative post-translational modifications. Front Physiol 2021;12:763417.

[77] Kameda M, Teruya T, Yanagida M et al. Frailty markers comprise blood metabolites involved in antioxidation, cognition, and mobility. Proc Natl Acad Sci USA 2020;117:9483–9489.

[78] Kanfi Y, Peshti V, Gil R et al. SIRT6 protects against pathological damage caused by diet-induced obesity. Aging Cell 2010;9:162–173.

[79] Kanfi Y, Naiman S, Amir G et al. The sirtuin SIRT6 regulates lifespan in male mice. Nature 2012;483:218–221.

[80] Kaufman-Szymczyk A, Majewski G, Lubecka-Pietruszewska K et al. The role of sulforaphane in epigenetic mechanisms, including interdependence between histone modification and DNA methylation. Int J Mol Sci 2015;16:29732–29743.

[81] Kawahara TL, Michishita E, Adler AS et al. SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span. Cell 2009;136:62–74.

[82] Kawano H, Otani M, Takeyama K et al. Studies on ergothioneine. VI. Distribution and fluctuations of ergothioneine in rats. Chem Pharm Bull (Tokyo) 1982;30:1760–1765.

[83] Kayrouz CM, Huang J, Hauser N et al. Biosynthesis of selenium- containing small molecules in diverse microorganisms. Nature 2022;610:199–204.

[84] Kehrer JP. The Haber–Weiss reaction and mechanisms of toxicity. Toxicology 2000;149:43–50.

[85] Kujoth GC, Hiona A, Pugh TD et al. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 2005;309:481–484.

[86] Lai R, Cui Q. How to stabilize carbenes in enzyme active sites without metal ions. J Am Chem Soc 2022;144:20739–20751.

[87] Lam-Sidun D, Peters KM, Borradaile NM. Mushroom-derived medicine? Preclinical studies suggest potential benefits of ergothioneine for cardiometabolic health. Int J Mol Sci 2021;22:3246.

[88] Leisinger F, Burn R, Meury M et al. Structural and mechanistic basis for anaerobic ergothioneine biosynthesis. J Am Chem Soc 2019;141:6906–6914.

[89] Lertratanangkoon K, Orkiszewski RS, Scimeca JM. Methyldonor deficiency due to chemically induced glutathione depletion. Cancer Res 1996;56:995–1005.

[90] Lertratanangkoon K, Wu CJ, Savaraj N et al. Alterations of DNA methylation by glutathione depletion. Cancer Lett 1997;120:149–156.

[91] Liu J, Magri L, Zhang F et al. Chromatin landscape defined by repressive histone methylation during oligodendrocyte differentiation. J Neurosci 2015;35:352–365.

[92] Liu T, Lv YF, Zhao JL et al. Regulation of Nrf2 by phosphorylation: consequences for biological function and therapeutic implications. Free Radic Biol Med 2021;168:129–141.

[93] López-Otín C, Blasco MA, Partridge L et al. The hallmarks of aging. Cell 2013;153:1194–1217.

[94] López-Otín C, Blasco MA, Partridge L et al. Hallmarks of aging: an expanding universe. Cell 2023;186:243–278.

[95] Markolovic S, Leissing TM, Chowdhury R et al. Structure–function relationships of human JmjC oxygenases- demethylases versus hydroxylases. Curr Opin Struct Biol 2016;41:62–72.

[96] Markova NG, Karaman-Jurukovska N, Dong KK et al. Skin cells and tissue are capable of using L-ergothioneine as an integral component of their antioxidant defense system. Free Radic Biol Med 2009;46:1168–1176.

[97] Matsumaru D, Motohashi H. The KEAP1–NRF2 system in healthy aging and longevity. Antioxidants (Basel) 2021;10:1929.

[98] Michalak EM, Burr ML, Bannister AJ et al. The roles of DNA, RNA and histone methylation in ageing and cancer. Nat Rev Mol Cell Biol 2019;20:573–589.

[99] Mills EL, Ryan DG, Prag HA et al. Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1. Nature 2018;556:113–117.

[100] Naowarojna N, Huang P, Cai Y et al. In vitro reconstitution of the remaining steps in ovothiol A biosynthesis: C–S lyase and methyltransferase reactions. Org Lett 2018;20:5427–5430.

[101] Naowarojna N, Irani S, Hu W et al. Crystal structure of the ergothioneine sulfoxide synthase from Candidatus chloracidobacterium thermophilum and structure-guided engineering to modulate its substrate selectivity. ACS Catal 2019;9:6955–6961.

[102] Nikodemus D, Lazic D, Bach M et al. Paramount levels of ergothioneine transporter SLC22A4 mRNA in boar seminal vesicles and cross-species analysis of ergothioneine and glutathione in seminal plasma. J Physiol Pharmacol 2011;62:411–419.

[103] Niu Y, Desmarais TL, Tong Z et al. Oxidative stress alters global histone modification and DNA methylation. Free Radic Biol Med 2015;82:22–28.

[104] Obayashi K, Kurihara K, Okano Y et al. L-Ergothioneine scavenges superoxide and singlet oxygen and suppresses TNF-alpha and MMP-1 expression in UV-irradiated human dermal fibroblasts. J Cosmet Sci 2005;56:17–27.

[105] Oumari M, Goldfuss B, Stoffels C et al. Regeneration of ergothioneine after reaction with singlet oxygen. Free Radic Biol Med 2019;134:498–504.

[106] Padeken J, Methot SP, Gasser SM. Establishment of H3K9-methylated heterochromatin and its functions in tissue differentiation and maintenance. Nat Rev Mol Cell Biol 2022;23:623–640.

[107] Pajares MA, Durán C, Corrales F et al. Modulation of rat liver S-adenosylmethionine synthetase activity by glutathione. J Biol Chem 1992;267:17598–17605.

[108] Pan H, Guan D, Liu X et al. SIRT6 safeguards human mesenchymal stem cells from oxidative stress by coactivating NRF2. Cell Res 2016;26:190–205.

[109] Pan HY, Ye ZW, Zheng QW et al. Ergothioneine exhibits longevity- extension effect in Drosophila melanogaster via regulation of cholinergic neurotransmission, tyrosine metabolism, and fatty acid oxidation. Food Funct 2022;13:227–241.

[110] Partridge L, Fuentealba M, Kennedy BK. The quest to slow ageing through drug discovery. Nat Rev Drug Discov 2020;19:513–532.

[111] Paul BD. Ergothioneine: a stress vitamin with antiaging, vascular, and neuroprotective roles? Antioxid Redox Signal 2022;36:1306–1317.

[112] Paul BD, Snyder SH. The unusual amino acid L-ergothioneine is a physiologic cytoprotectant. Cell Death Differ 2010;17:1134–1140.

[113] Pluskal T, Ueno M, Yanagida M. Genetic and metabolomic dissection of the ergothioneine and selenoneine biosynthetic pathway in the fission yeast, S. pombe, and construction of an overproduction system. PLoS One 2014;9:e97774.

[114] Rahman I, Gilmour PS, Jimenez LA et al. Ergothioneine inhibits oxidative stress- and TNF-alpha-induced NF-kappa B activation and interleukin-8 release in alveolar epithelial cells. Biochem Biophys Res Commun 2003;302:860–864.

[115] Rando TA, Chang HY. Aging, rejuvenation, and epigenetic reprogramming: resetting the aging clock. Cell 2012;148:46–57.

[116] Rezazadeh S, Yang D, Tombline G et al. SIRT6 promotes transcription of a subset of NRF2 targets by mono-ADP-ribosylating BAF170. Nucleic Acids Res 2019;47:7914–7928.

[117] Salama SA, Abd-Allah GM, Mohamadin AM et al. Ergothioneine mitigates cisplatin-evoked nephrotoxicity via targeting Nrf2, NF-κB, and apoptotic signaling and inhibiting γ-glutamyl transpeptidase. Life Sci 2021;278:119572.

[118] Salminen A, Kaarniranta K, Kauppinen A. Crosstalk between oxidative stress and SIRT1: impact on the aging process. Int J Mol Sci 2013;14:3834–3859.

[119] Satoh A, Brace CS, Rensing N et al. Sirt1 extends life span and delays aging in mice through the regulation of Nk2 homeobox 1 in the DMH and LH. Cell Metab 2013;18:416–430.

[120] Schumacher B, Pothof J, Vijg J et al. The central role of DNA damage in the ageing process. Nature 2021;592:695–703.

[121] Seebeck FP. In vitro reconstitution of Mycobacterial ergothioneine biosynthesis. J Am Chem Soc 2010;132:6632–6633.

[122] Sen P, Shah PP, Nativio R et al. Epigenetic mechanisms of longevity and aging. Cell 2016;166:822–839.

[123] Servillo L, Castaldo D, Casale R et al. An uncommon redox behavior sheds light on the cellular antioxidant properties of ergothioneine. Free Radic Biol Med 2015;79:228–236.

[124] Servillo L, D’onofrio N, Casale R et al. Ergothioneine products derived by superoxide oxidation in endothelial cells exposed to high-glucose. Free Radic Biol Med 2017;108:8–18.

[125] Shi Y. Histone lysine demethylases: emerging roles in development, physiology and disease. Nat Rev Genet 2007;8:829–833.

[126] Shimizu T, Masuo Y, Takahashi S et al. Organic cation transporter Octn1-mediated uptake of food-derived antioxidant ergothioneine into infiltrating macrophages during intestinal inflammation in mice. Drug Metab Pharmacokinet 2015;30:231–239.

[127] Singh V, Ubaid S. Role of silent information regulator 1 (SIRT1) in regulating oxidative stress and inflammation. Inflammation 2020;43:1589–1598.

[128] Singh CK, Chhabra G, Ndiaye MA et al. The role of sirtuins in antioxidant and redox signaling. Antioxid Redox Signal 2018;28:643–661.

[129] Smith E, Ottosson F, Hellstrand S et al. Ergothioneine is associated with reduced mortality and decreased risk of cardiovascular disease. Heart 2020;106:691–697.

[130] Stadtman TC. Selenocysteine. Annu Rev Biochem 1996;65:83–100.

[131] Stampfli AR, Seebeck FP. The catalytic mechanism of sulfoxide synthases. Curr Opin Chem Biol 2020;59:111–118.

[132] Stampfli AR, Goncharenko KV, Meury M et al. An alternative active site architecture for O(2) activation in the ergothioneine biosynthetic EgtB from Chloracidobacterium thermophilum. J Am Chem Soc 2019;141:5275–5285.

[133] Stoffels C, Oumari M, Perrou A et al. Ergothioneine stands out from hercynine in the reaction with singlet oxygen: resistance to glutathione and TRIS in the generation of specific products indicates high reactivity. Free Radic Biol Med 2017;113:385–394.

[134] Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003;3:768–780.

[135] Teruya T, Chen YJ, Kondoh H et al. Whole-blood metabolomics of dementia patients reveal classes of disease-linked metabolites. Proc Natl Acad Sci USA 2021;118:e2022857118.

[136] Tian G, Su H, Liu Y. Mechanism of sulfoxidation and C–S Bond formation involved in the biosynthesis of ergothioneine catalyzed by ergothioneine synthase (EgtB). ACS Catal 2018;8:5875–5889.

[137] Turrini NG, Kroepfl N, Jensen KB et al. Biosynthesis and isolation of selenoneine from genetically modified fission yeast. Metallomics 2018;10:1532–1538.

[138] Wang W, Sun W, Cheng Y et al. Role of sirtuin-1 in diabetic nephropathy. J Mol Med (Berl) 2019;97:291–309.

[139] Wardman P, Candeias LP. Fenton chemistry: an introduction. Radiat Res 1996;145:523–531.

[140] Wei WJ, Siegbahn PE, Liao RZ. Theoretical study of the mechanism of the nonheme iron enzyme egtB. Inorg Chem 2017;56:3589–3599.

[141] Williamson RD, Mccarthy FP, Manna S et al. L-(+)-Ergothioneine significantly improves the clinical characteristics of preeclampsia in the reduced uterine perfusion pressure rat model. Hypertension 2020;75:561–568.

[142] Wu LY, Cheah IK, Chong JR et al. Low plasma ergothioneine levels are associated with neurodegeneration and cerebrovascular disease in dementia. Free Radic Biol Med 2021;177:201–211.

[143] Wu P, Gu Y, Liao L et al. Coordination switch drives selective C–S bond formation by the non-heme sulfoxide synthases. Angew Chem Int Ed Engl 2022;61:e202214235.

[144] Xue F, Huang JW, Ding PY et al. Nrf2/antioxidant defense pathway is involved in the neuroprotective effects of Sirt1 against focal cerebral ischemia in rats after hyperbaric oxygen preconditioning. Behav Brain Res 2016;309:1–8.

[145] Yadan JC. Matching chemical properties to molecular biological activities opens a new perspective on L-ergothioneine. FEBS Lett 2022;596:1299–1312.

[146] Yamashita Y, Yamashita M. Identification of a novel selenium- containing compound, selenoneine, as the predominant chemical form of organic selenium in the blood of bluefin tuna. J Biol Chem 2010;285:18134–18138.

[147] Yang NC, Lin HC, Wu JH et al. Ergothioneine protects against neuronal injury induced by beta-amyloid in mice. Food Chem Toxicol 2012;50:3902–3911.

[148] Yang Y, Li W, Liu Y et al. Alpha-lipoic acid improves high-fat diet-induced hepatic steatosis by modulating the transcription factors SREBP-1, FoxO1 and Nrf2 via the SIRT1/LKB1/AMPK pathway. J Nutr Biochem 2014;25:1207–1217.

[149] Yang G, Weng X, Zhao Y et al. The histone H3K9 methyltransferase SUV39H links SIRT1 repression to myocardial infarction. Nat Commun 2017;8:14941.

[150] Zhang DD, Hannink M. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol Cell Biol 2003;23:8137–8151.

[151] Zhang H, Davies K JA, Forman HJ. Oxidative stress response and Nrf2 signaling in aging. Free Radic Biol Med 2015;88:314–336.

[152] Zhang S, Tomata Y, Sugiyama K et al. Mushroom consumption and incident dementia in elderly Japanese: the Ohsaki Cohort 2006 Study. J Am Geriatr Soc 2017;65:1462–1469.

[153] Zhang Y, Gonzalez-Gutierrez G, Legg KA et al. Discovery and structure of a widespread bacterial ABC transporter specific for ergothioneine. Nat Commun 2022;13:7586.

[154] Zhang J, Wu P, Zhang X et al. Coordination dynamics of iron is a key player in the catalysis of Non-heme enzymes. ChemBioChem 2023;24:e202300119.

[155] Zhu BZ, Mao L, Fan RM et al. Ergothioneine prevents copper- induced oxidative damage to DNA and protein by forming a redox-inactive ergothioneine–copper complex. Chem Res Toxicol 2011;24:30–34.

RIGHTS & PERMISSIONS

2023 The Author(s) 2023. Published by Oxford University Press on behalf of Higher Education Press.